CARA THERAPEUTICS INC (CARA) Stock Income Statement
NASDAQ:CARA - Nasdaq - US1407552082 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.14M | 20.97M | 41.90M | 23.00M | 135.10M | |||
| Cost Of Goods | 620.00K | 6.17M | 7.30M | N/A | N/A | |||
| Gross Profit | 6.52M | 14.79M | 34.60M | N/A | N/A | |||
| Operating Expenses | 59.34M | 136.29M | 122.10M | 112.10M | 129.70M | |||
| Research and Development | 32.76M | 108.38M | 91.80M | 82.60M | 107.70M | |||
| Selling, General, and Administrative Expenses | 26.39M | 27.65M | 30.10M | 29.30M | 21.70M | |||
| Operating Income | -52.82M | -121.50M | -87.50M | -89.10M | 5.40M | |||
| Interest Income/Expense | 2.83M | 3.59M | 2.10M | 600.00K | 2.30M | |||
| Other Income/Expense | -8.47M | -604.00K | N/A | N/A | N/A | |||
| Non Recurring Items | -12.80M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -71.27M | -118.51M | -85.50M | -88.40M | 7.70M | |||
| Income Tax | -398.00K | N/A | 0.00 | 0.00 | -700.00K | |||
| Net Income | -70.87M | -118.51M | -85.50M | -88.40M | 8.40M | |||
| EBITDA | -52.63M | -121.24M | -87.25M | -88.85M | 5.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -15.53 | -26.26 | -1.59 | -1.74 | 0.18 | |||
| Non GAAP EPS | N/A | -2.18 | -1.59 | -1.73 | 0.08 | |||
| Statistics | ||||||||
| Gross Profit Margin | 91.31% | 70.56% | 82.58% | N/A | N/A | |||
| Profit Margin | -992.95% | -565.21% | -204.06% | -384.35% | 6.22% | |||
| Operating Profit Margin | -740.06% | -579.43% | -208.83% | -387.39% | 4.00% | |||
All data in USD